My entire family skipped my wedding for my sister Celeste’s dinner and told me not to be dramatic about it. I didn’t beg anyone to come. I simply canceled every automatic payment I had been making for them and walked down the aisle without them. A month later, my phone showed 89 missed calls—and I answered none. Dad’s text arrived at 6:43 on a Thursday morning.

Vanguard Design Group officially folded three days later. Harrison & Croft bought the distressed assets and active contracts for absolute peanuts.

Leo was forced to step down and sign a humiliating non-disclosure agreement just to escape the lawsuits. Without his CEO salary, he and Chloe had to sell their massive suburban estate and move into a cramped townhouse. Predictably, Chloe’s brother Brayden was let go immediately, as Harrison & Croft didn’t employ underqualified nepotism hires.

Six months later, I stood on the unfinished top floor of the new downtown civic center, wearing a hardhat and looking out over the city skyline. The steel beams framed the sunset perfectly, exactly as I had calculated they would. My phone buzzed in my pocket. It was a text from my mother, asking if I could ‘help Leo out’ with a loan because he was struggling to find a job that matched his ‘executive experience.’

I smiled, deleted the message, and went back to work.

The heavy oak doors of the Aura Botanica boardroom clicked shut, sealing me inside with the two people who had spent the last decade turning my father’s legacy into their personal ATM.

My stepmother, Vivian, sat at the head of the long glass table, draped in a bespoke Chanel suit, her face pulled taut by the city’s most expensive plastic surgeon. Beside her sat my half-sister, Serena, furiously typing on her iPhone, completely disengaged from the reality of the room. Serena held the title of ‘Chief Marketing Officer,’ a role that mostly consisted of taking selfies with our products in five-star hotel lobbies in Dubai.

I sat opposite them, wearing my white lab coat over a plain black turtleneck. I had just come from the subterranean research and development lab, where I had spent the last fourteen hours stabilizing a volatile vitamin C derivative for our new night cream.

“Thank you for coming up, Harper,” Vivian said, folding her manicured hands on the table. Her voice was dripping with that rehearsed, maternal condescension she had perfected over twenty years. “We know how much you hate leaving your little basement. But this couldn’t wait.”

“I’m running a stability test on the new peptide serum, Vivian. What’s going on?” I asked, keeping my voice neutral.

Serena finally looked up from her phone, flashing a brilliant, hollow smile. “We’re selling the company, Harpie. We just signed the letter of intent this morning.”

I froze. “Selling the company? To who?”

“L’Éclat,” Vivian announced, dropping the name of the largest luxury cosmetics conglomerate in Europe like a royal decree. “They are acquiring Aura Botanica for one hundred and fifty million dollars. The deal closes in forty-five days, pending final due diligence.”

A heavy silence fell over the room. Aura Botanica was not just a brand; it was my entire life. When my father was alive, it was a struggling, niche apothecary. After he died, leaving the majority shares to Vivian and a minority sliver to me, I had buried my grief in the laboratory. I was a Ph.D. in cosmetic chemistry. Over seven years, I had single-handedly formulated the Luminescence line—a proprietary blend of botanical extracts and active enzymes that actually reversed cellular aging. It became a global phenomenon. It was the sole reason L’Éclat was offering nine figures.

“That’s… massive news,” I said slowly. “But my R&D department requires significant capital expansion if L’Éclat wants to scale up production. We need to discuss how the acquisition affects the lab.”

Vivian exchanged a brief, knowing look with Serena. It was the look of a predator cornering its prey.

“Actually, Harper, that’s why we called you up here,” Vivian said smoothly, sliding a thick manila folder across the glass table. “L’Éclat already has a massive R&D facility in Paris. They don’t need our little basement lab, and frankly, they don’t need a head chemist who lacks… executive polish.”

Serena scoffed. “No offense, Harpie, but you’re a lab rat. L’Éclat is about glamour, prestige, and high-society marketing. You don’t exactly fit the aesthetic of a global luxury brand. They want our brand equity and my marketing vision. They are going to outsource the actual mixing of the creams to their own factories.”

I looked at the folder. “What is this?”

“It’s a buyout agreement,” Vivian said, her tone hardening into cold business. “We are buying out your ten percent minority share in the company for two million dollars. In exchange, you resign as Head Chemist effective immediately, and you sign a comprehensive NDA and non-compete. You walk away today, and Serena and I will handle the L’Éclat transition.”

Two million dollars. It sounded like a lot of money to the average person. But on a one-hundred-and-fifty-million-dollar valuation, it was an insult of catastrophic proportions. They were actively robbing me of fifteen million dollars, kicking me out of the company my father built, and stripping me of the very formulas I had poured my soul into.

“You’re firing me,” I said, the words tasting like ash in my mouth. “I built this brand. My formulas are the only reason L’Éclat is even looking at you.”

“Don’t be dramatic, Harper. It’s unappealing,” Vivian sighed, examining her nails. “Your father left me in charge. Serena and I built the brand identity. You just mixed some plants in a beaker. Anyone can do that. Two million is more than generous for a glorified pharmacist. Sign the papers, pack up your beakers, and go take a vacation. You look exhausted.”

I stared at them. I saw the greed in Vivian’s eyes, the vapid entitlement in Serena’s posture. They genuinely believed I was just a drone in the basement, an expendable cog in their glamorous machine. They had spent years stepping on my back to reach the spotlight, and now that they were at the top, they were kicking away the ladder.

A familiar, icy calm washed over me. It was the same hyper-focused clarity I felt when balancing a delicate chemical equation. If they wanted to play corporate warfare, they were severely underestimating the chemist.